The Use of Beta-Adrenergic Blocking Agents in Anxiety Disorders and Schizophrenia
- 4 March 1983
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 3 (2P1), 101-117
- https://doi.org/10.1002/j.1875-9114.1983.tb03231.x
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Beta-blocking drugs and anxietyPsychosomatics, 1982
- NEUROENDOCRINE EFFECTS OF D,L-PROPRANOLOLThe Lancet, 1981
- Use of β-Blocking Drugs in Psychiatry and NeurologyDrugs, 1980
- Organic Brain Syndrome with PropranololNew England Journal of Medicine, 1979
- Clinical Pharmacokinetics of PropranololClinical Pharmacokinetics, 1979
- Effects of the isomeric forms of propranolol on central monoamine metabolism in regions of rat brainProgress in Neuro-Psychopharmacology, 1977
- Clinical Pharmacokinetics of β-Adrenoreceptor Blocking DrugsClinical Pharmacokinetics, 1976
- Use of ??-Adrenergic Receptor Blocking Drugs in PsychiatryDrugs, 1974
- Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance ProgramAmerican Heart Journal, 1973
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967